Search results
Results from the WOW.Com Content Network
Medtronic (NYS: MDT) announced Wednesday that it is offering a $2.5 million grant to Yale researchers who will independently review the safety of the company's controversial Infuse bone graft product.
When Army physician Timothy R. Kuklo was trying to get his study of Medtronic Inc.'s (MDT) Infuse bone-graft product published, he didn't say a word that he had received $800,000 from the medical ...
Eli Lilly and Company v. Medtronic, Inc., 496 U.S. 661 (1990), is a United States Supreme Court case related to patent infringement in the medical device industry. It held that 35 U.S.C. § 271(e)(1) [1] of United States patent law exempted premarketing activity conducted to gain approval of a device under the Federal Food, Drug, and Cosmetic Act from a finding of infringement.
Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), is a United States Supreme Court case in which the Court held that the pre-emption clause of the Medical Device Amendment bars state common-law claims that challenge the effectiveness or safety of a medical device marketed in a form that received premarket approval from the Food and Drug Administration.
Medtronic, Inc. v. Mirowski Family Ventures, LLC; R. Riegel v. Medtronic, Inc. This page was last edited on 4 April 2016, at 22:38 (UTC). Text is available under ...
Text messages, a whistleblower lawsuit and an internal investigation reveal the lengths to which Medtronic, the world’s largest medical device company, allegedly “groomed” doctors to overuse ...
In 1991, Medtronic and Mirowski entered into an agreement permitting Medtronic to practice certain Mirowski patents in exchange for royalty payments. In 2007, the parties found themselves in the midst of an "infringement" dispute, and Mirowski gave Medtronic notice that it believed seven new Medtronic products violated various claims contained in two of its patents, [a] which dealt with ...
In 2005, Michelson sold many of his spine-related patents to Medtronic for $1.35 billion, [13] placing him on the Forbes 400 list. [14] A legal battle with Medtronic over the origins of the patents preceded the sale. In 2004, Michelson cross-filed in response to Medtronic's 2001 suit, and was awarded financial damages for both lawsuits by the ...